The estimated Net Worth of Robert S Howe is at least $1.52 Million dollars as of 17 February 2022. Mr Howe owns over 11,537 units of Conformis stock worth over $941,480 and over the last 5 years he sold CFMS stock worth over $26,834. In addition, he makes $552,291 as CFO & Treasurer at Conformis.
Mr has made over 3 trades of the Conformis stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 11,537 units of CFMS stock worth $7,499 on 17 February 2022.
The largest trade he's ever made was selling 11,537 units of Conformis stock on 17 February 2022 worth over $7,499. On average, Mr trades about 3,830 units every 46 days since 2020. As of 17 February 2022 he still owns at least 416,584 units of Conformis stock.
You can see the complete history of Mr Howe stock trades at the bottom of the page.
Robert S Howe is the CFO & Treasurer at Conformis.
As the CFO & Treasurer of Conformis, the total compensation of Mr Howe at Conformis is $552,291. There are 2 executives at Conformis getting paid more, with Mark Augusti having the highest compensation of $2,853,750.
Mr Howe is 51, he's been the CFO & Treasurer of Conformis since . There are 9 older and 5 younger executives at Conformis. The oldest executive at Conformis Inc. is Kenneth Fallon, 80, who is the Independent Chairman of the Board.
Robert's mailing address filed with the SEC is C/O CONFORMIS INC, 600 TECHNOLOGY PARK DRIVE, BILLERICA, MA, 01821.
Over the last 9 years, insiders at Conformis have traded over $10,769,806 worth of Conformis stock and bought 583,200 units worth $267,840 . The most active insiders traders include Capital Management Llcchris..., Philipp Lang, and Mark A Augusti. On average, Conformis executives and independent directors trade stock every 21 days with the average trade being worth of $122,083. The most recent stock trade was executed by Mark A Augusti on 7 May 2022, trading 22,396 units of CFMS stock currently worth $10,302.
our mission patients vary in more ways than gender, race, and size. at conformis, we believe that optimizing implant fit and performance requires a patient-specific approach. our mission is to provide best-in-class, patient-specific implants and instrumentation that offer unique advantages over traditional orthopedic implants. we start with a simple idea: make the implant fit the patient rather than forcing the patient to fit the implant. our implants are individually sized and shaped to fit to each patient’s unique anatomy, providing precise anatomic fit and preserving healthy tissue. our disposable, patient-specific cutting and placement guides also eliminate many of the tools required for traditional orthopedic surgery and simplify surgical technique. by combining our personalized implants with our unique instrumentation, a surgeon is able to provide a custom solution that preserves more of a patient’s joint and minimizes surgical trauma. our company conformis, inc. is a privately h
Conformis executives and other stock owners filed with the SEC include: